Analysts say Trump’s picks for high-profile positions like secretary of state and attorney general reflect a desire to tap ...

This story first appeared in The 19th. President-elect Donald Trump intends to nominate anti-vaccine conspiracy theorist ...

Needham analyst Quinn Bolton has maintained their bullish stance on QBTS stock, giving a Buy rating yesterday. Quinn Bolton has given his Buy ...

In a report released yesterday, Etzer Darout from BMO Capital reiterated a Buy rating on Acrivon Therapeutics, Inc. (ACRV – Research ...

Here are some of the headlines from this past week in the Missoulian. To read the full stories, click the link on each ...

Powell's hawkish comments are casting a pall on markets as the initial optimism for President-elect Donald Trump's policies starts to wear off. The S&P has already reversed one-third of its ...

New rules require drugmakers to be clearer and more direct in TV drug ads when explaining their medications' risks and side ...

On Thursday, Halozyme Therapeutics, Inc. (NASDAQ: HALO) submitted a non-binding proposal to Evotec SE (NASDAQ: EVO) to acquire the German company for 11.00 euros per share in cash, implying a fully ...

Bristol Myers Squibb was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for three drugs, 1-1/2 months after a federal judge ...

Non-small cell lung cancer (NSCLC) remains a predominant cause of cancer-related mortality worldwide. In recent years, immune checkpoint inhibitors (ICIs) have emerged as a transformative therapeutic ...

Given Trump's promises to make his next term more extreme than his last, it's easy to freak out and feel powerless. We have ...

The state Department of Motor Vehicles on Thursday joined the Transportation Security Administration at the Albany ...